Sunesis Pharmaceuticals
| Region | Nordamerika |
| ISIN | US8673288747 |
| Sektor | Biotechnologie |
| Website | https://www.sunesis.com/ |
Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics. With a passion to advance novel drugs, we are inspired to make a difference in cancer patients' lives.
| Titel | Autor | Datum |
|---|---|---|
|
Risikoarmes "Peak Play" mit Multibagger-Potenzial
|
sharedeals | vor ungefähr 11 Monaten |
| Titel | Datum |
|---|---|
| MISC Berhad -- Moody's announces completion of a periodic review of ratings of MISC Berhad | vor 8 Tagen |
| Hubline, MISC unit ink MoU to explore opportunities port management and marine... | vor ungefähr einem Monat |
| BCG Digital Ventures and MISC Announce Co-Investment in Three Ventures to Disrupt the Maritime Solutions Space with Deep Tech | vor ungefähr einem Monat |
| MISC, BCGDV co-invest in 3 startups to disrupt shipping industry with deep tech | vor ungefähr einem Monat |
| MISC sees better prospect as oil demand recovers | vor ungefähr einem Monat |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Suedzucker (1 Artikel) | |
| Stockholm IT Ventures AB (1 Artikel) | |
| Tahoe Resources (1 Artikel) | |
| Telit Communications (3 Artikel) | |
| Alle anzeigen | |